Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
Kedudukan dalam Saham
#3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Harga Saham
$4.87
Modal Pasaran
$4.36B
Perubahan (1 hari)
-5.47%
Perubahan (1 tahun)
-15.62%
Negara
CN
Perdagangan Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Kategori
Healthcare
Bilangan saham terbitan bagi Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Bilangan saham terbitan setakat October 2026: 0
Menurut laporan kewangan terkini dan harga saham Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, bilangan saham terbitan semasa ialah 0. Pada akhir October 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336) dari 2006 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2025 | 617.38M | -0.11% |
| 2024 | 618.05M | 0.70% |
| 2023 | 613.78M | -0.40% |
| 2022 | 616.22M | 2.37% |
| 2021 | 601.95M | 2.42% |
| 2020 | 587.73M | 10.22% |
| 2019 | 533.24M | 4.51% |
| 2018 | 510.22M | 0.00% |
| 2017 | 510.22M | 0.86% |
| 2016 | 505.85M | 0.00% |
| 2015 | 0.00 | 0.00% |
| 2014 | 0.00 | 0.00% |
| 2013 | 0.00 | -100.00% |
| 2012 | 508.39M | -1.58% |
| 2011 | 516.57M | 8.92% |
| 2010 | 474.28M | 0.00% |
| 2009 | 0.00 | 0.00% |
| 2008 | 0.00 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 0.00 | - |
BE
|
|
| 62.19M | - |
NL
|
